« Updated Obese Women Less Likely To Be Tested For Some Cancers (healthday) | Main | Topic J&j Adds Cancer Warning To Diabetic Foot Gel (reuters) »
Updated Amgen Presents Preclinical And Clinical Data From Oncology Programs
By admin2 | July 17, 2008
Amgen (NASDAQ:AMGN) announced data generated by the company’s robust oncology research and development programs in the areas of apoptosis (programmed cell death) and cell growth regulation. The data, presented at the American Association for Cancer Research (AACR) Annual Meeting in San Diego were from five preclinical studies evaluating anti-tumor activity, pharmacodynamics, and potential pre-clinical and clinical biomarkers for investigational molecules AMG 655, AMG 479 and AMG 102.
(Link)
Topics: Cancer |